We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.89%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$67.1B
AUM Growth
+$1.83B
Cap. Flow
+$1.87B
Cap. Flow %
2.78%
Top 10 Hldgs %
10.65%
Holding
4,083
New
504
Increased
1,541
Reduced
1,228
Closed
364

Sector Composition

Rank Sector Weight
1 Energy 11.41%
2 Technology 9.4%
3 Healthcare 8.95%
4 Consumer Discretionary 8.78%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIMX
3576
Himax Technologies
HIMX
$2.2B
$168K ﹤0.01%
20,900
-506,861
-96% -$3.45M
PHLT
3577
DELISTED
Performant Healthcare Inc
PHLT
$168K ﹤0.01%
51,935
-19,961
-28% -$62.1K
MTEM
3578
DELISTED
Molecular Templates, Inc.
MTEM
$168K ﹤0.01%
+252
New +$167K
CIE
3579
PUT
DELISTED
Cobalt International Energy, Inc
CIE
$168K ﹤0.01%
1,153
CSR
3580
Centerspace
CSR
$936M
$167K ﹤0.01%
2,344
-6,763
-74% -$490K
FF icon
3581
Future Fuel
FF
$204M
$167K ﹤0.01%
+12,975
New +$152K
PKD
3582
DELISTED
Parker Drilling Company
PKD
$166K ﹤0.01%
3,350
+2,445
+270% +$136K
ACRE
3583
Ares Commercial Real Estate
ACRE
$252M
$165K ﹤0.01%
+14,484
New +$167K
ADVM
3584
DELISTED
Adverum Biotechnologies
ADVM
$163K ﹤0.01%
+1,004
New +$339K
HIL
3585
DELISTED
Hill International, Inc. Common Stock
HIL
$156K ﹤0.01%
+29,737
New +$142K
WILN
3586
DELISTED
Wi-LAN Inc.
WILN
$156K ﹤0.01%
+67,300
New +$159K
DXLG icon
3587
Destination XL Group
DXLG
$34.7M
$155K ﹤0.01%
30,952
+12,002
+63% +$59.6K
ONCT
3588
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$153K ﹤0.01%
74
+30
+68% +$42.6K
HWCC
3589
DELISTED
Houston Wire & Cable Company
HWCC
$153K ﹤0.01%
15,402
-3,184
-17% -$29.9K
PSV
3590
DELISTED
Hermitage Offshore Services Ltd.
PSV
$153K ﹤0.01%
+1,883
New +$171K
GLAD icon
3591
Gladstone Capital
GLAD
$425M
$152K ﹤0.01%
9,598
-2,192
-19% -$37.4K
GNCA
3592
DELISTED
Genocea Biosciences, Inc.
GNCA
$152K ﹤0.01%
+1,386
New +$129K
SB icon
3593
Safe Bulkers
SB
$781M
$148K ﹤0.01%
+46,039
New +$160K
PGNX
3594
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$145K ﹤0.01%
19,496
-55,238
-74% -$334K
STML
3595
DELISTED
Stemline Therapeutics, Inc.
STML
$145K ﹤0.01%
+12,342
New +$171K
GFI icon
3596
Gold Fields
GFI
$29.2B
$142K ﹤0.01%
44,140
-124,613
-74% -$467K
LCTX icon
3597
Lineage Cell Therapeutics
LCTX
$257M
$141K ﹤0.01%
48,264
+1,528
+3% +$5.92K
AVP
3598
DELISTED
Avon Products, Inc.
AVP
$140K ﹤0.01%
22,300
-3,635,811
-99% -$27M
TRR
3599
DELISTED
Trc Companies
TRR
$138K ﹤0.01%
+13,638
New +$127K
VNCE icon
3600
Vince Holding Corp
VNCE
$76.2M
$134K ﹤0.01%
1,121
-5,698
-84% -$954K

Similar funds

D.E. Shaw & Co's Q2 2015 Portfolio in Review

As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.

By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.

  • D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
  • D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
  • D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
  • D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
  • D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
  • D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.